Milliman’s Post

 📌 Save the date: Using Milliman’s Data Assets to Unlock Value for Life Science Companies In the dynamic and competitive life sciences industry, leveraging data effectively can be the key to unlocking new opportunities and driving strategic success.    Join Jessica Naber, Kevin Pierce, and Rebecca Smith for our third installment of Milliman Life Sciences Insights Live. Here's what you can expect: 💡 Compelling case studies highlighting how comprehensive administrative claims datasets have been used to enhance market access initiatives.  💡Insights into leveraging real-world evidence for informed decision-making and planning.  💡How Milliman’s data-driven approach supports navigating the complexities of the U.S. healthcare market Register now!   📆 Wednesday, January 29, 2025  ⏱️ 10:00 AM PST // 12:00 PM CST // 1:00 PM EST    PS – You might want to turn on your event notifications on LinkedIn so you don’t miss the reminder to join the livestream.   #Milliman #MillimanLifeSciencesLive #LifeSciences

Using Milliman's Data Assets to Unlock Value for Life Science Companies

Using Milliman's Data Assets to Unlock Value for Life Science Companies

www.linkedin.com

Olaf Lodbrok

Pioneering data-driven innovation in healthcare and precision medicine

2mo

Thank youi, very interesting !

Like
Reply
Kim Sorlien

Product and Analytics Leader

2mo

Excellent presentations and insights! Thank you.

Like
Reply
Ashwin Anand

Patient Journey Analytics | AI B2B SaaS | Pharmaceutical Executive | Solution Design & Business Development | Strategy & GTM | 10+ Years in Fortune 500

2mo

curious on which data dimensions you use relative to OOP exposure. rise in premiums etc.?

Like
Reply
Jeremy Engdahl-Johnson

Senior Director of Global Communications at Milliman

2mo

How can we better understand what information / fields are in the data and how we can use them?

Like
Reply
Jeremy Engdahl-Johnson

Senior Director of Global Communications at Milliman

2mo

How does a project typically work when incorporating data like this?

Like
Reply
Ashwin Anand

Patient Journey Analytics | AI B2B SaaS | Pharmaceutical Executive | Solution Design & Business Development | Strategy & GTM | 10+ Years in Fortune 500

2mo

to clarify..your team can look at historical utilization trends across setting of care and then project forward expected out of pocket costs by patient payer mix (commercial vs. medicare etc.) Thanks

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics